Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00509743 · ClinicalTrials.gov registry record · Phase 1
Study to Assess Effects of Age, Weight, and Body Composition on the Pharmacokinetics of IV Diclofenac Sodium
A Phase 1 study, sponsored by Javelin Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 89
- Enrollment target
NCT00509743 is a Phase 1 study that has completed, run by Javelin Pharmaceuticals. The registered enrollment target is 89 participants.
The verdict
NCT00509743, a Phase 1 study, has completed, sponsored by Javelin Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 89 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effects of age, weight, and body composition on the pharmacokinetic profile, safety, and tolerability of intravenous diclofenac sodium (DIC075V) in adult volunteers.
Interventions
- DRUG Intravenous diclofenac sodium (DIC075V)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2007-09 |
| Est. Completion | 2008-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00509743
The ClinicalTrials.gov registry entry for NCT00509743 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Javelin Pharmaceuticals, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intravenous diclofenac sodium (DIC075V) is the first listed.
NCT00509743 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00509743 about?
NCT00509743 is a clinical study titled "Study to Assess Effects of Age, Weight, and Body Composition on the Pharmacokinetics of IV Diclofenac Sodium". The purpose of this study is to assess the effects of age, weight, and body composition on the pharmacokinetic profile, safety, and tolerability of intravenous diclofenac sodium (DIC075V) in adult volunteers.
What is the current status of trial NCT00509743?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 89 participants. The study started on 2007-09. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00509743?
The interventions under investigation include: Intravenous diclofenac sodium (DIC075V) (DRUG).
Who is sponsoring clinical trial NCT00509743?
This trial is sponsored by Javelin Pharmaceuticals, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.